Home Contact Us Help

August 9 The Clinical Use of Incretin-Based Therapy in Type 2 Diabetes

Evaluation & Post Test for
The Clinical Use of Incretin-Based Therapy in Type 2 Diabetes
Thursday, August 9, 2012 • 1:00 – 2:40 pm, San Diego, CA

For Attendees seeking AMA PRA Category 1 credit.

The Clinical Use of Incretin-Based Therapy in Type 2 Diabetes
Thursday, August 9, 2012 • 1:00 – 2:40 pm
San Diego, CA
For Attendees seeking AMA PRA Category 1 credit.


Learning Objectives
At the conclusion of this symposium, participants will be able to:
* List the benefits and limitations of incretin-based therapies
* Differentiate the clinical effects among the glucagon-like peptide-1 receptor agonists and
dipeptidyl peptidase-4 inhibitors
* Identify strategies for handling real world challenges when managing patients with type 2 diabetes mellitus using incretin-based therapy

Agenda
1:00 - 1:15 PM Buffet Lunch
1:15 - 1:25 PM Introduction and Case Study
Wendy Wright, MS, RN, ARNP, FNP, FAANP
1:25 - 2:00 PM Clinical Utilization of GLP-1R Agonists and DPP-4 Inhibitors
Mansur Shomali, MD, CM
2:00 - 2:30 PM Solving Clinical Conundrums
B. Scott Urquhart, PA-C, DFAAPA
2:30 – 2:40 Q&A

Target Audience
This CE symposium is intended for nurse practitioners and physician assistants with an interest in the management of patients with type 2 diabetes mellitus.

Continuing Education Information
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Illinois Academy of Family Physicians/Family Practice Education Network and Primary Care Education Consortium. The Illinois Academy of Family Physicians/Family Practice Education Network is accredited by the ACCME to provide continuing medical education for physicians.

AMA PRA Category 1
The Illinois Academy of Family Physicians/Family Practice Education Network designates this live activity, The Clinical Use of Incretin-Based Therapy in Type 2 Diabetes, for a maximum of 1.5 AMA PRA Category 1 credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Non-physicians who attend this symposium and successfully complete the requirements will be issued a certificate of participation upon successful completion of the program requirements (see end of syllabus).


Physician Assistants
The American Academy of Physician Assistants accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.


Commercial Support
This CE symposium is supported by an educational grant from Novo Nordisk Inc.

Disclosure Information
As part of their efforts to ensure balance, independence, objectivity, and scientific rigor, the joint
sponsors of this CE symposium have required the faculty and all others involved in the development of the content to disclose any relationships they may have with commercial companies that have a product or service relevant to this symposium.
Mansur Shomali discloses that he has no conflicts of interest to resolve related to this symposium.
B. Scott Urquhart discloses that he has no conflicts of interest to resolve related to this symposium.

Illinois Academy of Family Physicians/Family Practice Education Network staff disclose that they have no conflicts of interest to resolve related to this symposium.
Primary Care Education Consortium staff disclose that they have no conflicts of interest to resolve related to this symposium.

Off-Label Disclosure
The faculty have been instructed to identify investigational drugs or devices or discussion of drugs or devices that is outside of labeling currently approved by the US Food and Drug

Administration.
Faculty Affiliations & Biographies
Mansur Shomali, MD, CM
B. Scott Urquhart, PA-C, DFAAPA
Wendy Wright, MS, RN, ARNP, FNP, FAANP

To view this course, log in or register from the Home Page.